Syria marks first international card transaction in more than 15 years with Mastercard and QNB GroupAugust 28, 2026
STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 PeopleAugust 28, 2026
Electronic Device Solution Inc. Expands Push into Middle East Defense Market with GaN-Based RF TechnologyAugust 28, 2026
Novo Nordisk’s amycretin achieves breakthrough obesity trial resultsJanuary 24, 2025 Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting its stock by 6.87% as the drug exhibits safety and potential as a next-gen obesity treatment.
